切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2017, Vol. 06 ›› Issue (04) : 198 -202. doi: 10.3877/cma.j.issn.2095-3259.2017.04.002

所属专题: 专题评论 文献

专家论坛

妊娠期肝衰竭母儿预后的评估
尹玉竹1,(), 张培珍1   
  1. 1. 510630 广州,中山大学附属第三医院产科
  • 收稿日期:2017-07-14 出版日期:2017-11-18
  • 通信作者: 尹玉竹

Prognostic assessment of mother and infant in live failure during pregnancy

Yuzhu Yin1(), Peizhen Zhang1   

  • Received:2017-07-14 Published:2017-11-18
  • Corresponding author: Yuzhu Yin
引用本文:

尹玉竹, 张培珍. 妊娠期肝衰竭母儿预后的评估[J]. 中华产科急救电子杂志, 2017, 06(04): 198-202.

Yuzhu Yin, Peizhen Zhang. Prognostic assessment of mother and infant in live failure during pregnancy[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2017, 06(04): 198-202.

妊娠期肝衰竭病情凶险,孕妇和胎儿死亡率高。乙型肝炎病毒感染和妊娠期急性脂肪肝是导致我国妊娠期肝衰竭的主要原因,有效的病情评估和及时终止妊娠是改善母儿预后的主要手段。终末期肝病模型评分、肝功能CTP评分和Swansea标准对急慢性肝衰竭和妊娠期急性脂肪肝预后有一定的评估价值,但尚需在临床工作中进一步探讨。

Live failure during pregnancy often evolves critically and carries out high maternal-fetus mortality. Infection of hepatitis B virus and acute fatty liver of pregnancy (AFLP) are the most common causes of liver failure during pregnancy in China. Prognosis can be improved with effective evaluation of illness state and timely termination of pregnancy. The model for end-stage liver disease (MELD) scoring system, Child-Turcotte-Pugh (CTP) scoring system of liver function and Swansea criteria can be used to predicting the prognosis of acute-chronic hepatitis B liver failure and AFLP, but it should be further explored in clinical work.

表1 CTP评分系统[20]
[1]
中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012年版)[J]. 中华临床感染病杂志,2012, 5(6):321-327.
[2]
曹健英,陈宝花,蒋佩茹. 妊娠合并肝衰竭患者的病死危险因素分析[J]. 现代妇产科进展,2013, 22(9):730-733.
[3]
Li XM, Deng LZ, Shen HM, et al. Liver synthetic function in predicting the prognosis of pregnancy complicating fulminant hepatitis[J]. Chin Med J (Engl), 2007, 120(24):2311-2313.
[4]
Knox TA, Olans LB. Liver disease in pregnancy[J]. N Engl J Med, 1996, 335(8):569-576.
[5]
Joshi D, James A, Quaglia A, et al. Liver disease in pregnancy[J]. The Lancet, 2010, 375(9714):594-605.
[6]
Than NN, Neuberger J. Liver abnormalities in pregnancy[J]. Best Pract Res Clin Gastroenterol, 2013, 27(4):565-575.
[7]
Jena P, Sheela CN, Venkatachala RP, et al. Obstetric outcome in women with chronic liver disease[J]. J Obstet Gynaecol India, 2017, 67(4):263-269.
[8]
Shaheen AA, Myers RP. The outcomes of pregnancy in patients with cirrhosis: a population-based study[J]. Liver Int, 2010, 30(2):275-283.
[9]
Ko H, Yoshida EM. Acute fatty liver of pregnancy[J]. Can J Gastroenterol, 2006, 20(1):25-30.
[10]
13th Asia-Pacific Congress of Clinical Microbiology and Infection Consensus Guidelines for diagnosis and treatment of liver failure[J]. Hepatobiliary Pancreat Dis Int, 2013, 12(4):346-354.
[11]
Ding G, Li Z, Zhang L, et al. Circulating full-length cytokeratin 18 for predicting prognosis of hepatitis B virus-related acute-on-chronic liver failure patients with lamivudine treatment[J]. Hepatol Res, 2016, 46(4):329-334.
[12]
Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33(2):464-470.
[13]
Kamath PS, Kim WR. The model for end-stage liver disease (MELD)[J]. Hepatology, 2007, 45(3):797-805.
[14]
Zheng MH, Shi KQ, Fan YC, et al. A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure[J]. Clin Gastroenterol Hepatol, 2011, 9(4):351-356.
[15]
于琳,曾荔苹,光晓燕. 妊娠合并重型肝炎患者MELD评分分析与终止妊娠时机[J]. 现代中西医结合杂志,2010, 19(5):524-525, 528.
[16]
杨越波,邓柳枝,李小毛. MELD评分对晚期妊娠合并重型肝炎预后的评价作用[C]. 南京:第二届围产医学新进展高峰论坛,2010.
[17]
Sun QF, Ding JG, Xu DZ, et al. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model[J]. J Viral Hepat, 2009, 16(7):464-470.
[18]
Xu X, Liu X, Ling Q, et al. Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure[J]. PLoS One, 2013, 8(3):e58738.
[19]
Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis[J]. Gut, 2006, 55 Suppl 6:i1-i12.
[20]
Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices[J]. Br J Surg, 1973, 60:646-649.
[21]
谢仕斌,吴元凯,朱建芸,等. 慢加急性肝衰竭预后评分系统的建立与评估[J]. 中山大学学报(医学科学版), 2011, 32(6):834-840.
[22]
Knight M, Nelson-Piercy C, Kurinczuk JJ, et al. A prospective national study of acute fatty liver of pregnancy in the UK[J]. Gut, 2008, 57(7):951-956.
[23]
Goel A, Ramakrishna B, Zachariah U, et al. How accurate are the Swansea criteria to diagnose acute fatty liver of pregnancy in predicting hepatic microvesicular steatosis?[J]. Gut, 2011, 60(1):138-139, 139-140.
[24]
Meng J, Wang S, Gu Y, et al. Prenatal predictors in postpartum recovery for acute fatty liver of pregnancy: experiences at a tertiary referral center[J]. Arch Gynecol Obstet, 2016, 293(6):1185-1191.
[25]
Holt EW, Guy J, Gordon SM, et al. Acute liver failure caused by herpes simplex virus in a pregnant patient: is there a potential role for therapeutic plasma exchange?[J]. J Clin Apher, 2013, 28(6):426-429.
[26]
Qu YY, Zeng H, Guo XY, et al. Retrospective analysis of anesthetic and perioperative management in patients of acute fatty liver of pregnancy[J]. Zhonghua Yi Xue Za Zhi, 2017, 97(24):1878-1882.
[27]
Yu CB, Chen JJ, Du WB, et al. Effects of plasma exchange combined with continuous renal replacement therapy on acute fatty liver of pregnancy[J]. Hepatobiliary Pancreat Dis Int, 2014, 13(2):179-183.
[28]
Papafragkakis H, Singhal S, Anand S. Acute fatty liver of pregnancy[J]. South Med J, 2013, 106(10):588-593.
[29]
Zhou G, Zhang X, Ge S. Retrospective analysis of acute fatty liver of pregnancy: twenty-eight cases and discussion of anesthesia[J]. Gynecol Obstet Invest, 2013, 76(2):83-89.
[1] 马中正, 杨云川, 马翔, 周迟, 丁丁, 霍俊一, 徐楠, 崔培元, 周磊. 胰腺癌双硫死亡相关的lncRNA预后模型的构建及免疫反应研究[J]. 中华普通外科学文献(电子版), 2024, 18(05): 368-376.
[2] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[3] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[4] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[5] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[6] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[7] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[8] 袁庆港, 刘理想, 张亮, 周世振, 高波, 丁超, 管文贤. 尿素-肌酐比值(UCR)可预测结直肠癌患者术后的长期预后[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 506-509.
[9] 黄福, 王黔, 金相任, 唐云川. VEGFR2、miR-27a-5p在胃癌组织中的表达与临床病理参数及预后的关系研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 558-561.
[10] 张瑜, 姜梦妮. 基于DWI信号值构建局部进展期胰腺癌放化疗生存获益预测模型[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 657-664.
[11] 伍细蓉, 徐立文, 陈亚琼. 基于LPR和FARI构建肝衰竭患者生存预后模型[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 675-681.
[12] 刘军, 丘文静, 孙方昊, 李松盈, 易述红, 傅斌生, 杨扬, 罗慧. 在体与离体劈离式肝移植在儿童肝移植中的应用比较[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 688-693.
[13] 唐诗, 薛传优, 叶兴, 张鸿举, 戴瑞. 急性病毒性肝炎患者血脂、血糖、蛋白、尿酸变化特点及其与预后的关联[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 396-399.
[14] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
[15] 闫战涛, 王辉, 周梓迪, 史勇强, 陈铜兵. 胃淋巴上皮瘤样癌三级淋巴结构特征及其与预后的相关性[J]. 中华临床医师杂志(电子版), 2024, 18(05): 455-461.
阅读次数
全文


摘要